Eric J. Topol, M.D., to Present Late-Breaking Lecture About Advancements in Genomics of Cardiovascular Disease at ACC's 57th Annual Scientific Session

Presentation by Leader of Innovative Scripps Genomic Medicine Program to

Include Data on Novel Genomic Markers for Cardiac Disease

Mar 26, 2008, 01:00 ET from Scripps Health

    SAN DIEGO, March 26 /PRNewswire/ -- Eric J. Topol, M.D., chief academic
 officer of Scripps Health and director of the Scripps Translational Science
 Institute, will present a late-breaking lecture about advancements in the
 genomics of cardiovascular disease at the American College of Cardiology's
 (ACC) 57th Annual Scientific Session in Chicago.
     Dr. Topol's presentation on March 31 will include data concerning new,
 compelling genomic markers for myocardial infarction, coronary artery
 disease, atrial fibrillation and abnormal lipoproteins. A panel discussion
 about the progress, limitations, caveats and future issues in
 cardiovascular genomic medicine will follow the presentation.
Who: Eric J. Topol, M.D., Chief Academic Officer, Scripps Health; Director of Scripps Translational Science Institute; Professor of Translational Genomics, The Scripps Research Institute What: Late-breaking lecture about advancements in the genomics of cardiovascular disease When: 3:30 p.m.-4:30 p.m. CDT, March 31 Where: North Hall B1, McCormick Place, Chicago About Scripps Genomic Medicine An initiative of Scripps Health and The Scripps Research Institute, Scripps Genomic Medicine is an innovative program in which genomic researchers, clinicians and other specialists are working side-by-side to advance medicine. Current projects include the genotyping of tens of thousands of individuals of diverse ancestry to identify and define genes that are responsible for major disease and the underpinnings of health. Through The Scripps Translational Science Institute, this basic research will be translated into drug discovery programs and, ultimately, clinical trials. These trials, launched through Scripps Advanced Clinical Trials, will test individualized treatment and prevention strategies in collaboration with pharmaceutical, medical device, biotechnology and diagnostic companies. For more information, visit About Scripps Health Founded in 1924 by philanthropist Ellen Browning Scripps, Scripps Health is a non-profit community health system based in San Diego. Scripps treats a half-million patients annually through the dedication of 2,600 affiliated physicians and 11,000 employees among its five acute-care hospital campuses, home health care services, and an ambulatory care network of clinics, physician offices and outpatient centers. Recognized as a national leader in the prevention, diagnosis, and treatment of disease, Scripps is also at the forefront of clinical research and graduate medical education. For more information, visit

SOURCE Scripps Health